Inventor · disambiguated record
Matt Aaron Tschantz
Also filed as: TSCHANTZ MATT · TSCHANTZ MATT AARON
15 granted patents·8 pending applications·524 citations·filing 2001–2024
92Inventor score
Files withBOEHRINGER INGELHEIM INT9BOEHRINGER INGELHEIM PHARMA5IMMUNESENSOR THERAPEUTICS INC5BARBOSA ANTONIO J M2BARBOSA JR ANTONIO JOSE DEL MORAL1
Top patents by PatentIndex Score
23 records- 0198US6770639B2Heterocyclic compounds useful as inhibitors of tyrosine kinasesBOEHRINGER INGELHEIM PHARMA·Filed 2002·Granted Aug 3, 2004·205 cites·5 claims
- 0298US6506769B2Heterocyclic compounds useful as inhibitors of tyrosine kinasesBOEHRINGER INGELHEIM PHARMA·Filed 2001·Granted Jan 14, 2003·240 cites·32 claims
- 0392US11873291B2Quinoline cGAS antagonist compoundsIMMUNESENSOR THERAPEUTICS INC·Filed 2021·Granted Jan 16, 2024·3 cites·52 claims
- 0492US7601714B2Pyrimidine derivatives useful as inhibitors of PKC-thetaBOEHRINGER INGELHEIM PHARMA·Filed 2005·Granted Oct 13, 2009·33 cites·9 claims
- 0586US9975882B2Heteroaromatic compounds as BTK inhibitorsBOEHRINGER INGELHEIM INT·Filed 2016·Granted May 22, 2018·5 cites·40 claims
- 0686US6852748B1Derivatives of [6,7-dihydro-5H-imidazo[1,2-a]imidazole-3-sulfonyl]-pyrrolidine-2-carboxylic acid amideBOEHRINGER INGELHEIM PHARMA·Filed 2003·Granted Feb 8, 2005·24 cites·17 claims
- 0782US2025115579A1QUINOLINE cGAS ANTAGONIST COMPOUNDSIMMUNESENSOR THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0880US12134609B2Quinoline cGAS antagonist compoundsIMMUNESENSOR THERAPEUTICS INC·Filed 2023·Granted Nov 5, 2024·0 cites·23 claims
- 0979US7572921B2Substituted benzylimidazoles useful for the treatment of inflammatory diseasesBOEHRINGER INGELHEIM INT·Filed 2006·Granted Aug 11, 2009·4 cites·6 claims
- 1076US12091387B2Quinoline cGAS antagonist compoundsIMMUNESENSOR THERAPEUTICS INC·Filed 2023·Granted Sep 17, 2024·0 cites·29 claims
- 1176US7468382B2Pyridine derivatives useful as inhibitors of PKC-thetaBOEHRINGER INGELHEIM INT·Filed 2006·Granted Dec 23, 2008·3 cites·6 claims
- 1275US12281078B2Quinoline cGAS antagonist compoundsIMMUNESENSOR THERAPEUTICS INC·Filed 2023·Granted Apr 22, 2025·0 cites·26 claims
- 1373US7462637B2Derivatives of [6,7-dihydro-5H-imidazo[1,2--a]imidazole-3-sulfonyl]-pyrrolidine-2-carboxylic acid amideBOEHRINGER INGELHEIM PHARMA·Filed 2004·Granted Dec 9, 2008·6 cites·8 claims
- 1469US2021009567A1Heteroaromatic compounds as btk inhibitorsBOEHRINGER INGELHEIM INT·Filed 2020·Application pending·0 cites
- 1565US2020055843A1Heteroaromatic compounds as btk inhibitorsBOEHRINGER INGELHEIM INT·Filed 2019·Application pending·0 cites
- 1663US8552205B2Derivatives of 6,7-dihydro-5H-imidazo[1,2-alpha]imidazole-3-carboxylic acid amidesBARBOSA JR ANTONIO JOSE DEL MORAL·Filed 2008·Granted Oct 8, 2013·1 cites·49 claims
- 1763US2019092759A1Heteroaromatic compounds as btk inhibitorsBOEHRINGER INGELHEIM INT·Filed 2018·Application pending·0 cites
- 1862US2018222893A1Heteroaromatic compounds as btk inhibitorsBOEHRINGER INGELHEIM INT·Filed 2018·Application pending·0 cites
- 1960US2018030037A1Heteroaromatic compounds as btk inhibitorsBOEHRINGER INGELHEIM INT·Filed 2017·Application pending·0 cites
- 2053US2008287410A1Pyrimidine derivatives useful as inhibitors of pkc-thetaBARBOSA ANTONIO J M·Filed 2008·Application pending·0 cites
- 2144US9533999B2Fused thiazin-3-ones as KCA3.1 inhibitorsBOEHRINGER INGELHEIM INT·Filed 2013·Granted Jan 3, 2017·0 cites·28 claims
- 2240US2008318929A1Pyrimidine Derivatives Useful as Inhibitors of Pkc-ThetaBARBOSA ANTONIO J M·Filed 2006·Application pending·0 cites
- 2331US8481750B2Derivatives of 6,7-dihydro-5H-imidazo[1,2-α]imidazole-3-carboxylic acid amidesKOWALSKI JENNIFER A·Filed 2010·Granted Jul 9, 2013·0 cites·12 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →